Downes et al. described two women with only neurological presentation and without any hematological anomalies [11]. Patients with TTP receiving tissue plasminogen activator (tPA) or unnecessary procedures can cause catastrophic outcomes. This evidence concerns the gene PLAT and thrombotic thrombocytopenic purpura.